Xian Gmei Li
Corporate Secretary bei MICROPORT CARDIOFLOW MEDTECH CORPORATION
Profil
Xian Gmei Li is currently a Joint Secretary at MicroPort CardioFlow Medtech Corp.
She previously worked as a Senior Manager at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and as a Manager-Investor Relations at Sinopec Shanghai Petrochemical Co., Ltd.
Ms. Li received an undergraduate degree from Zhengzhou University in 2002.
Aktive Positionen von Xian Gmei Li
| Unternehmen | Position | Beginn |
|---|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Corporate Secretary | 27.10.2020 |
Ehemalige bekannte Positionen von Xian Gmei Li
| Unternehmen | Position | Ende |
|---|---|---|
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Corporate Officer/Principal | 01.01.2020 |
| SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED | Investor Relations Contact | 01.12.2014 |
Ausbildung von Xian Gmei Li
| Zhengzhou University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED | Energy Minerals |
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
